Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ULTRALIFE CORP Director's Dealing 2015

Jan 5, 2015

34105_dirs_2015-01-05_a38e60f4-2b84-44a8-81d3-36ede890aa96.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ULTRALIFE CORP (ULBI)
CIK: 0000875657
Period of Report: 2015-01-01

Reporting Person: POPIELEC MICHAEL D (Director, President and CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-01-01 Common Stock; $.10 par value M 17361 Acquired 221141 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2015-01-01 Restricted Stock Units $0 J 12639 Disposed 2020-12-30 Common Stock (30000) Direct

Footnotes

F1: Represents the conversion of 30,000 restricted stock units previously awarded to Michael D. Popielec on June 4, 2013 upon the vesting of such restricted stock units on January 1, 2015. The Company retained 12,639 of the 30,000 shares of common stock issuable to Michael D. Popielec in satisfaction of his individual minimum statutory tax withholding obligation at a price per share determined as of the vesting date.